key: cord-0793316-n632dbun authors: Maltezou, Helena C.; Poland, Gregory A.; Poland, Caroline M. title: Immunization of Healthcare Personnel: A Continuing Issue date: 2022-05-10 journal: Vaccine X DOI: 10.1016/j.jvacx.2022.100169 sha: 70cb1ea4c47aa1d234941ed910fd944136fcdd2a doc_id: 793316 cord_uid: n632dbun nan 47 Similarly, safe and effective COVID-19 vaccines were deployed within less than one Skepticism and rejection of COVID-19 53 vaccination among HCP and the public emerged as a major public health issue since 54 the release of the first COVID-19 vaccines in 2020 [14]. In the United States alone, as 55 of September 15, 2021, 30% of HCP in hospitals were still unvaccinated [15]. , several countries adopted mandatory COVID-19 vaccination policies 59 for HCP as a prerequisite for employment and most likely others will follow Moreover, studies from many countries consistently indicate low influenza vaccination 61 rates and significant immunity gaps against many VPDs (e.g., up to 17% for measles, 62 up to 25% for mumps, up to 18.6% for rubella, up to 16.7% for varicella, and up to 35% 63 for hepatitis B) among HCP Immunization of HCP is even more imperative 68 and taken on greater urgency as global vaccination coverage rates have dropped the 69 past two years due to disruption of vaccination services [26]. and adolescence [27]. In the rapidly evolving scientific landscape of the past 195 15 COVID-19 vaccination coverage among hospital-based healthcare personnel 197 reported through the Department of Health and Human Services Unified 198 Hospital Data Surveillance System COVID-19 vaccination significantly reduces morbidity 202 and absenteeism among healthcare personnel: a prospective multicenter study Wise J. COVID-19: France and Greece make vaccination mandatory for 207 healthcare workers COVID vaccination to be mandatory for NHS staff in England from 209 spring 2022 211 Implications of suboptimal COVID-19 vaccination coverage in Florida and Texas Promoting COVID-19 vaccine acceptance: recommendations from the Lancet 215 Commission on Vaccine Refusal, Acceptance, and Demand in the USA Lambach P, the Independent Expert 226 Advisory Group for Health Worker Influenza Vaccination. factors and 227 considerations for establishing and improving seasonal influenza vaccination of 228 health workers 231 Expanding mandatory healthcare personnel immunization beyond influenza: 232 Impact of a broad immunization program with enhanced accountability Educating 238 children and adolescents about vaccines: a review of current literature Developing vaccine policy: attributes of "just policy" 241 and a proposed template to guide decision and policy making Immunization education for internal medicine residents: a cluster-245 randomized controlled trial Vaccine Education Spectrum Disorder: the importance 247 of incorporating psychological and cognitive models into vaccine education The need for a multi-disciplinary perspective on 250 vaccine hesitancy and acceptance Improving COVID-19 vaccine 255 acceptance: including insights from human decision-making under conditions 256 of uncertainty and human-centered design Vaccine hesitancy and health care providers: using 258 the preferred cognitive styles and decision-making model and empathy tool to 259 make progress Authors Contributions Maltezou: conceptualization, writing of original draft, approval of final 272 manuscript Poland: conceptualization, contribution to writing, approval of final 274 manuscript Poland: conceptualization, contribution to writing, approval of final Poland is the chair of a Safety Evaluation Committee for novel 285 investigational vaccine trials being conducted by Merck Research Laboratories Poland provides consultative advice on vaccine development to Merck & Co These activities have been reviewed by 291 the Mayo Clinic Conflict of Interest Review Board and are conducted in compliance 292 with Mayo Clinic Conflict of Interest policies. Dr. Poland holds patents related to 293 vaccinia, influenza, and measles peptide vaccines. Dr. Poland has received grant 294 funding from ICW Ventures This research has been reviewed by the Mayo Clinic Conflict of Interest 296 Review Board and was conducted in compliance with Mayo Clinic Conflict of Interest 297 policies Poland provides consultative advice to Sanofi Pasteur Maltezou has no conflict of interest to declare